A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients

NCT01305239 · clinicaltrials.gov ↗
TERMINATED
Status
398
Enrollment
INDUSTRY
Sponsor class

Stopped See termination reason in detailed description.

Conditions

Interventions

Sponsor

Pfizer